Company · founded 2007
Manzanita Pharmaceuticals (United States)
Woodside, United States · manzanitapharmaceuticals.com
- Citations, last 5 years
- 0
- Works, last 5 years
- 0
- h-index
- 0
- Scientists listed
- 0
- Grants since 2016
- 5
Grants received
2024–2026 · research · R44
Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer
Stephen B Kahl · Manzanita Pharmaceuticals (United States) · funded by National Institutes of Health
2024–2025 · grant · Standard Grant
SBIR Phase I: Domestication of Western Lupine - Manzanita Cooperative
Christopher Hendrickson · Manzanita Pharmaceuticals (United States) · funded by National Science Foundation
2024–2026 · research · R44
Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer
Stephen B Kahl · Manzanita Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2021 · research · R44
Nonclinical development of Nervelight, an intra-operative peripheral nerve imaging agent
Stephen B Kahl · Manzanita Pharmaceuticals (United States) · funded by National Institutes of Health
2017–2019 · research · R44
Nonclinical development of Nervelight, an intra-operative peripheral nerve imaging agent
Stephen B Kahl · Manzanita Pharmaceuticals (United States) · funded by National Institutes of Health